Humanase’s Organ-on-a-Chip is a next-gen drug discovery platform that replicates major human organ functions like the heart, liver, and brain. Using microfluidic channels to supply nutrients and remove waste, it evaluates drug efficacy and toxicity in a human-like environment. Humanase offers heart, liver, and brain chips, along with toxicity analysis services for biotech and research firms. The company also develops disease models for fatty liver, liver cancer, pancreatic cancer, Alzheimer's, and Parkinson's, bridging the gap in animal and clinical tests. Its core strengths include high reproducibility, convenience, and cost-efficiency, requiring no expensive equipment while enabling rapid cell injection and large-scale testing.